Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
January 02, 2025
Renew your membership for 2025 if you have not already done so to stay connected to our global community. Keep access to your member-exclusive resources, including discounts to our annual meetings, such as ENDO 2025 taking place in San Francisco, CA, USA, July 12-15, and exclusive networking and professional development opportunities.
January 14, 2025
Applications are now open for the Early Investigator Awards, honoring outstanding achievements by early career endocrine researchers. Apply now to showcase your work and its impact within the global endocrine community. Applications close January 15, 2025.
January 02, 2025
Celebrate excellence in endocrinology with the Laureate Awards. Honor your peers for their groundbreaking research, exceptional clinical care, leadership, mentorship, and international contributions. Nominate a colleague or apply by January 21, 2025. Nominate or Apply
January 14, 2025
There is no better place to share your research than ENDO. Taking place July 12-15 in San Francisco, CA, ENDO 2025 will feature thousands of scientific presentations. Submitting an abstract for presentation at ENDO earns media coverage for your work, connects you with scientific investigators with similar interests, and helps drive future research.
January 10, 2025
The US Congress failed to pass final legislation for FY25 funding or many of the Society's health priorities at the end of 2024. Progress was made in the EU, however, when the European Commission announced a ban on bisphenol-A, a known endocrine-disrupting chemical, in food contact materials.
Need more info?
Learn more about the advantages of membership
December 10, 2024
Early life exposure to a class of endocrine-disrupting chemicals (EDCs) called polychlorinated biphenyls (PCBs) may lead to behavioral problems in rats, according to a new animal study published in the Journal of the Endocrine Society.
November 12, 2024
Vitamin D supplements may lower blood pressure in older people with obesity and taking more than the Institutes of Medicine’s (IOM) recommended daily dose does not provide additional health benefits, according to new research published in the Journal of the Endocrine Society.
November 06, 2024
Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications.
January 14, 2025
The authors report a 35-year-old woman who presented with secondary amenorrhea and prominent features of hyperandrogenism, including acne vulgaris, male-pattern alopecia, deepening of voice, and hirsutism.
January 14, 2025
This work aims to determine whether supplementation with vitamin D3 or omega-3 fatty acids vs placebo for 2 years improves physical performance measures.
January 14, 2025
In the present study, we show for the first time that increased circulating FGF23 levels in obese humans correlate with increased expression of adipose Fgf23 and both positively correlate with BMI.
